“Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation: Pidotimod in SARS-CoV-2 vaccination” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022023. doi:10.4084/MJHID.2022.023.